A Bioequivalence Study of APX001 High-load and Low-load Tablets

Clinical trial NCT05491733 · COMPLETED

Trial details

NCT number: NCT05491733
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Invasive Fungal Infections

Start date: 2021-03-02
Primary completion: 2021-05-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.